Key Findings: Year-End 2024
PE: There were 86 exits totaling $6.7B in 2024.
Exits via M&A transactions accounted for the majority of exit activity (74%), while secondary buyouts contributed the largest share of exit value (71%) in the first nine months of 2024.
VC: In 2024, there were 40 exits totaling $5.2B, primarily driven by M&A.
The largest exit of 2024 was the acquisition of Hamiltonbased Fusion Pharmaceuticals, acquired by AstraZeneca for $3.3B.
PE: Privatizations in 2024 accounted for a significant portion of total dollars invested, with 14 companies going private.
2024 saw a significant surge in overall private equity investment, with $27.5B deployed across 658 deals
VC: The largest deal in 2024 was the $1.24 billion funding round raised by BC-based legaltech company Clio.
The final quarter of 2024 saw an additional $1.4B invested across 124 deals, bringing the year’s total to $7.9B invested across 592 deals
